105 related articles for article (PubMed ID: 8694534)
1. TAG-72 expression and its role in the biological evaluation of human colorectal cancer.
Guadagni F; Roselli M; Cosimelli M; Ferroni P; Spila A; Cavaliere F; Arcuri R; Carlini S; Mariotti S; Gandolfo GM; Casciani CU; Greiner JW; Schlom J
Anticancer Res; 1996; 16(4B):2141-8. PubMed ID: 8694534
[TBL] [Abstract][Full Text] [Related]
2. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
[TBL] [Abstract][Full Text] [Related]
3. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of the new tumor marker TAG-72.
Guadagni F; Roselli M; Ferroni P; Amato T; Colcher D; Greiner JW; Schlom J
Anticancer Res; 1991; 11(4):1389-94. PubMed ID: 1746895
[TBL] [Abstract][Full Text] [Related]
5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients.
Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Tedesco M; Grassi A; Casale V; Cavaliere F; Greiner JW
J Surg Oncol Suppl; 1991; 2():16-20. PubMed ID: 1892526
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer.
Spila A; Ferroni P; Cosimelli M; D'Alessandro R; Carone MD; Aloe S; Tedesco M; Mancini R; Casale V; Carlini S; Casciani CU; Roselli M; Guadagni F
Anticancer Res; 1999; 19(2B):1363-8. PubMed ID: 10365107
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of TAG-72 as a serum marker in ovarian and breast carcinoma.
Esposito G; Panza N; Mansi L; De Matteis A; D'Aiuto G; Labonia V; Riccardi F; Pacilio G; Salvatore M
J Nucl Med Allied Sci; 1990; 34(2):88-93. PubMed ID: 2246676
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
11. [Expression of tumor-associated antigen LEA and its significance for pathological diagnosis].
Feng H; Song JD
Ai Zheng; 2002 Jun; 21(6):658-62. PubMed ID: 12452070
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.
Spila A; Ferroni P; Cosimelli M; D'Alessandro R; Abbolito MR; Mariotti S; Aloe S; Carone MD; Graziano F; Tedesco M; Martini F; Mancini R; Stigliano V; Roselli M; Guadagni F
Anticancer Res; 2001; 21(2B):1263-70. PubMed ID: 11396197
[TBL] [Abstract][Full Text] [Related]
13. Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease.
Filella X; Molina R; Jo J; Bedini JL; Joseph J; Ballesta AM
Bull Cancer; 1992; 79(3):271-7. PubMed ID: 1392166
[TBL] [Abstract][Full Text] [Related]
14. Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis.
Ilantzis C; Jothy S; Alpert LC; Draber P; Stanners CP
Lab Invest; 1997 May; 76(5):703-16. PubMed ID: 9166289
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
Gaspar MJ; De Miguel J; García Díaz JD; Díez M
Anticancer Res; 2008; 28(5B):2947-52. PubMed ID: 19031938
[TBL] [Abstract][Full Text] [Related]
16. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
17. [The value of serum tumor-associated glycoprotein 72 (TAG 72) in the diagnosis of malignancies].
Sun G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):447-50. PubMed ID: 1303818
[TBL] [Abstract][Full Text] [Related]
18. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
Grotowski M
Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
[TBL] [Abstract][Full Text] [Related]
19. What types of colorectal cancer overexpress the MAGE protein?
Koketsu S; Watanabe T; Kazama S; Ishihara S; Komuro Y; Nagawa H
Hepatogastroenterology; 2004; 51(60):1648-52. PubMed ID: 15532796
[TBL] [Abstract][Full Text] [Related]
20. Apocrine carcinoma, adenopathies, and raised TAG-72 serum tumor marker.
Santos-Juanes J; Bernaldo de Quirós JF; Galache Osuna C; Sánchez del Río J; Allende MT; Folgueras MV; Soto de Delás J
Dermatol Surg; 2004 Apr; 30(4 Pt 1):566-9. PubMed ID: 15056154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
